Company · CIK 1771885

# Quantum Biopharma Ltd.

| CIK | [1771885](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001771885) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | A6 |
| Listed | QNTM (Nasdaq) |
| First annual or quarterly report | 2020-03-04 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-276264 | Shelf Effective | 2023-12-26 | 2025-12-22 | 6 |

## Filings

 7

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-12-22 | [424B5](https://www.sec.gov/Archives/edgar/data/1771885/000175392625001935/0001753926-25-001935-index.htm) Shelf takedown | 333-276264 | 0001753926-25-001935 |
| 2025-10-31 | [424B5](https://www.sec.gov/Archives/edgar/data/1771885/000175392625001676/0001753926-25-001676-index.htm) Shelf takedown | 333-276264 | 0001753926-25-001676 |
| 2024-08-27 | [424B5](https://www.sec.gov/Archives/edgar/data/1771885/000165495424011106/0001654954-24-011106-index.htm) Shelf takedown | 333-276264 | 0001654954-24-011106 |
| 2024-02-20 | [424B5](https://www.sec.gov/Archives/edgar/data/1771885/000143774924004666/0001437749-24-004666-index.htm) Shelf takedown | 333-276264 | 0001437749-24-004666 |
| 2024-01-04 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1771885/999999999524000047/9999999995-24-000047-index.htm) Declared effective | 333-276264 | 9999999995-24-000047 |
| 2023-12-26 | [F-3](https://www.sec.gov/Archives/edgar/data/1771885/000165495423015955/0001654954-23-015955-index.htm) Shelf registered | 333-276264 | 0001654954-23-015955 |
| 2023-07-19 | [RW](https://www.sec.gov/Archives/edgar/data/1771885/000106299323015081/0001062993-23-015081-index.htm) Withdrawn | 333-254995 | 0001062993-23-015081 |

[All filings of this company](https://equitycapital.markets/filings?cik=1771885) · [CSV](https://equitycapital.markets/filings.csv?cik=1771885)

---
Source page: https://equitycapital.markets/company/1771885 · Data: U.S. SEC EDGAR · CC BY 4.0